| Members |
targetComponentId |
| epoetin beta 2000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
Product containing precisely epoetin beta 6667 unit/1 milliliter conventional release solution for injection (clinical drug) |
| epoetin beta 30.000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,6 ml |
Product containing precisely epoetin beta 50000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| epoetin beta 3000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
Epoetin beta 10000 unit/mL solution for injection |
| epoetin beta 4000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
Product containing precisely epoetin beta 13333 unit/1 milliliter conventional release solution for injection (clinical drug) |
| epoetin beta 5000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
Product containing precisely epoetin beta 16667 unit/1 milliliter conventional release solution for injection (clinical drug) |
| epoetin beta 500 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
Epoetin beta 1667 unit/mL solution for injection |
| epoetin beta 6000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
Epoetin beta 20000 unit/mL solution for injection |
| epoprostenol 1,5 mg pulver og solvent til infusionsvæske, hætteglas |
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for injection vial |
| epoprostenol 500 µg pulver og solvent til infusionsvæske, hætteglas |
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| Epoprostenol sodium 0.5mg/vial powder |
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| Epoprostenol sodium 1.5mg/vial powder |
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for injection vial |
| Epstein's pearl of mouth |
Gingival cyst of neonate (disorder) |
| Epstein's pearl of mouth |
Epstein's pearl of palate (disorder) |
| eptacog alfa |
Product containing eptacog alfa (medicinal product) |
| Eptifibatide 2mg/mL injection |
Eptifibatide 2 mg/mL solution for injection |
| eptifibatid 2 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
Eptifibatide 2 mg/mL solution for injection |
| udligning af forskel i benlængde i form af forlængelse eller forkortning vha. epifysiodese |
Bone lengthening |
| udligning af forskel i benlængde i form af forlængelse eller forkortning vha. epifysiodese |
Bone shortening procedure |
| Equid herpesvirus 1 |
Equid herpesvirus 4 (organism) |
| Equid herpesvirus 1 |
Equid herpesvirus 1 (organism) |
| Equine rhinovirus |
Genus Erbovirus (organism) |
| Equine rhinovirus |
Equine rhinitis A virus (organism) |
| Equine rhinovirus |
Equine rhinitis B virus (organism) |
| hesteart |
Equus caballus (organism) |
| hesteart |
Genus Equus (organism) |
| Erbium compound |
Erbium (substance) |
| Erdheim cystic medial necrosis of aorta |
Medionecrosis of aorta |
| Erdheim cystic medial necrosis of aorta |
Congenital aneurysm of ascending aorta |
| eriktil dysfunktion forårsaget af generel sygdom |
Secondary erectile dysfunction (disorder) |
| fund vedr. erektion |
Penile erection |
| ergometrinmaleat + oxytocin 500 µg/5 enheder/ml injektionsvæske, opløsning, ampul a 1 ml |
Product containing precisely ergometrine maleate 500 microgram/1 milliliter and oxytocin 5 unit/1 milliliter conventional release solution for injection (clinical drug) |
| ergometrinmaleat 500 µg/1 ml injektionsvæske |
Product containing precisely ergometrine maleate 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Erodium moschatum |
Erodium moschatum |
| Erosion &/or ectropion of cervix |
Ectropion of cervix |
| Erosion &/or ectropion of cervix |
Ectropion of cervix |
| Erosion &/or ectropion of cervix |
Erosion of cervix |
| Erosion &/or ectropion of cervix |
Erosion of cervix |
| Erosion og ektropi af cervix uteri |
Ectropion of cervix |
| Erosion og ektropi af cervix uteri |
Erosion of cervix |
| Erosive vulvitis |
Erosive vulvitis (disorder) |
| Erosive vulvitis |
Vulval cellulitis (disorder) |
| Eruptivt kollagenom |
Eruptive collagenoma of skin (disorder) |
| Eruptivt kollagenom |
Connective tissue nevus of skin (disorder) |
| Erwinia-art |
Erwinia |
| Erysipeloid |
Seal finger |
| Erysipeloid |
Erysipelothrix |
| Erysipeloid |
Erysipeloid (disorder) |
| Erysipelothrix (disease) |
Erysipelothrix |
| Erysipelothrix (disease) |
Seal finger |
| Erysipelothrix (disease) |
Erysipeloid (disorder) |
| Erysipelothrix (disease) |
Infection caused by Erysipelothrix rhusiopathiae |
| Erysipelothrix-septikæmi |
Sepsis caused by Erysipelothrix (disorder) |
| Erysipelothrix-art |
Erysipelothrix |
| Erysipelothrix: [unspecified infection] or [Rosenbach] |
Erysipeloid (disorder) |
| Erysipelothrix: [unspecified infection] or [Rosenbach] |
Seal finger |
| Erysipelothrix: [unspecified infection] or [Rosenbach] |
Erysipelothrix |
| Erythema annulare centrifugum |
Erythema annulare centrifugum (disorder) |
| Erythema annulare centrifugum |
Familial annular erythema |
| Erythema gyratum |
Erythema gyratum repens |
| Erythema gyratum |
Erythema annulare centrifugum (disorder) |
| Erythema iris |
Erythema multiforme |
| Erythema marginatum |
Erythema marginatum in acute rheumatic fever |
| Erythema marginatum |
Annular erythema |
| Erytematøs tilstand |
Erythroderma (disorder) |
| Erythematous conditions NOS |
Erythroderma (disorder) |
| Erythematous disorder |
Erythroderma (disorder) |
| Erythematous pinta plaque |
Erythematous pinta plaque |
| Erythematous pinta plaque |
Hyperchromic lesions of pinta |
| Erythrasma |
Erythrasma |
| Erythrasma |
Infection caused by Corynebacterium minutissimum (disorder) |
| Erythremia |
Acute erythroid leukemia |
| Erythremia |
Polycythemia vera |
| Erythroblastosis fetalis |
Perinatal anemia (disorder) |
| Erythroblastosis fetalis |
Neonatal anemia |
| Erythroblastosis fetalis |
Hemolytic disease of fetus OR newborn due to isoimmunization (disorder) |
| Sænkningsreaktion, ikke nærmere specificeret |
Erythrocyte sedimentation (observable entity) |
| Sænkningsreaktion, ikke nærmere specificeret |
Erythrocyte sedimentation rate measurement (procedure) |
| Erythrocyte sedimentation rate (& level) |
Erythrocyte sedimentation rate measurement (procedure) |
| Erythrocyte sedimentation rate (& level) |
Erythrocyte sedimentation (observable entity) |
| Erythrocyte sedimentation rate (& level) |
Erythrocyte sedimentation (observable entity) |
| Erythrocyte sedimentation rate (& level) |
Erythrocyte sedimentation rate measurement (procedure) |
| Erythrocyte sedimentation rate |
Erythrocyte sedimentation (observable entity) |
| Erythrocyte sedimentation rate |
Erythrocyte sedimentation rate measurement (procedure) |
| Erythroderma |
Erythrodermic eczema (disorder) |
| Erythroderma |
Erythroderma (disorder) |
| Erythromycin &/or macrolide poisoning |
Erythromycin poisoning |
| Erythromycin &/or macrolide poisoning |
Poisoning by macrolide |
| erythromycin 125 mg/5 ml sukkerfri suspension |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| erythromycin 250 mg/5 ml sukkerfri suspension |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| erythromycin 500 mg/5 ml sukkerfri suspension |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin adverse reaction |
Erythromycin adverse reaction (disorder) |
| Erythromycin adverse reaction |
Allergy to erythromycin |
| Erythromycin adverse reaction |
Hypersensitivity to erythromycin |
| Erythromycin or macrolide poisoning NOS |
Poisoning by macrolide |
| Erythromycin or macrolide poisoning NOS |
Erythromycin poisoning |
| følsomhed over for erythromycin |
Hypersensitivity to erythromycin |
| følsomhed over for erythromycin |
Allergy to erythromycin |
| bivirkning af erythropoietin |
Erythropoietin receptor agonist adverse reaction |
| overdosis af erythropoietin |
Erythropoietin receptor agonist overdose (disorder) |
| Erythropoietin product |
Erythropoietin receptor agonist-containing product |
| behandling med erythropoietin |
Therapy using erythropoietin receptor agonist |
FHIR